General News ยท Pan-African
Tramadol in Africa: How drug trafficking thrives where pain relief is scarce
By: Fekria Mohsen
An investigation into the tramadol trade across Africa, examining how limited access to legitimate pain relief drives illicit markets, distribution networks, and public health ramifications.
Tramadol remains a widely used analgesic across many African countries, but limited access to legitimate pain relief and regulation gaps have contributed to a thriving illicit market. The publication examines how shortages in medical supply, high treatment costs, and weak regulatory frameworks enable trafficking networks to move tramadol across borders, often with little scrutiny from authorities. Communities facing chronic pain and cancer care deficits may rely on informal channels, while counterfeit and substandard tablets raise safety concerns. Public health implications include rising misuse, dependence, and the risk of overdose, alongside the strain on healthcare systems ill-equipped to monitor and treat substance use. Experts highlight the need for strengthened pharmaceutical governance, improved access to affordable, regulated analgesics, and coordinated regional enforcement to disrupt trafficking while ensuring patients receive legitimate medicines. The piece calls for data-driven policy responses that balance pain relief with controlled distribution to prevent misuse and protect vulnerable populations.